<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04764045</url>
  </required_header>
  <id_info>
    <org_study_id>NP-FM-19</org_study_id>
    <nct_id>NCT04764045</nct_id>
  </id_info>
  <brief_title>The Significance of Peripheral Input</brief_title>
  <official_title>The Significance of Peripheral Input in Patients With Post Surgery Neuropathic Pain: Evaluation of Trigger Point Anesthesia. A Double-blind, Randomized, Controlled Exploratory Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to examine trigger point injections of local anesthetics, in patients&#xD;
      with post operative neuropathic pain, determine changes in sensory disturbances such as&#xD;
      allodynia, hyperalgesia and thermal sensitivity and examine whether trigger point injections&#xD;
      will attenuate pain in rest and activity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The presence of cutaneous trigger points in the surgical incision of patients with&#xD;
      post-surgery pain has been shown in our pain clinic, all patients have persistent pain for&#xD;
      more than 3 month and different sensory disturbances.&#xD;
&#xD;
      Examinations with trigger point injections of local anesthetics have been used to determine&#xD;
      the influence of peripheral changes and the significance of afferent input on persistent&#xD;
      post-surgery neuropathic pain.&#xD;
&#xD;
      In the present study the investigators will document the influence of cutaneous trigger point&#xD;
      injections for both subjective pain experience and objective findings in the area such as&#xD;
      allodynia, hyperalgesia and thermal sensitivity. The investigators expect reduction in&#xD;
      spontaneous pain intensity and de-crease in peripheral sensory disturbances and will&#xD;
      determine the significance of peripheral input in persistent neuropathic pain.&#xD;
&#xD;
      The investigators aim to investigate whether injection of local anesthesia into trigger&#xD;
      points compared with placebo (saline) injection will attenuate pain and normalize abnormal&#xD;
      sensations, such as hyperalgesia and allodynia. The investigators believe this to be an&#xD;
      important investigation to understand the mechanisms behind chronic post-surgery pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in worst pain in rest and in activity</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in worst pain assessed on a visual analogue scale (VAS, 0-100 mm) at rest and after stair walking/abduction of shoulder, before and after trigger point injections compared to baseline pain score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in area of sensory disturbances</measure>
    <time_frame>30 minutes</time_frame>
    <description>Area of pin-prick hyperalgesia, using von Frey filament 60 g and brush allodynia, using Somdic brush, assessed pre- and post-injection. Areas identified at a control day between the two intervention days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in warm and cold detection, threshold and tolerance before and after intervention in area with hyperalgesia compared to normal skin</measure>
    <time_frame>30 minutes</time_frame>
    <description>Detection, thresholds and tolerance for cold and heat within the hyperalgesia area compared to normal skin at the contralateral site, before and after trigger point injections. All measures made with Somedic MSA Thermal Stimulator</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine injection in trigger points</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine injection 1 ml in all trigger points in and around scar after operation in knee, shoulder and foot, one time, duration 3 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo injection in trigger points</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline injection 1 ml in all trigger points in and around scar after operation in knee, shoulder and foot, one time, duration 3 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Injection of 1 ml Ropivacaine in all trigger points in and around scar. Injection of 1 ml saline in all trigger points in and around scar.</description>
    <arm_group_label>Placebo injection in trigger points</arm_group_label>
    <arm_group_label>Ropivacaine injection in trigger points</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years old&#xD;
&#xD;
          -  Patients with chronic pain (daily VAS pain scores &gt;30 mm) for at least 3 months after&#xD;
             knee, shoulder or foot surgery&#xD;
&#xD;
          -  Patients with at least one identifiable trigger point in relation to incision from the&#xD;
             knee, shoulder or foot surgery. A trigger point is defined as an ar-ea in relation to&#xD;
             the incision from surgery, in which a light pressure from a cotton pin radiate pain to&#xD;
             the nearby area, and exudes a motor reflex causing withdrawal of the leg&#xD;
&#xD;
          -  A written informed consent to participate in the study after having fully understood&#xD;
             the contents of the protocol and restrictions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who cannot cooperate&#xD;
&#xD;
          -  Patients who cannot understand or speak Danish.&#xD;
&#xD;
          -  Patients with allergy to the drugs used in the study&#xD;
&#xD;
          -  Patients in treatment with vitamin K antagonists.&#xD;
&#xD;
          -  Patients with other pain conditions&#xD;
&#xD;
          -  Patients with diabetes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400 NV</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne R Saugbjerg, RN, MHH</last_name>
      <phone>+45 2145 4462</phone>
      <email>marianne.roerbaek.saugbjerg@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Finn B Moltke, MD</last_name>
      <phone>+45 2116 0444</phone>
      <email>finn.borgbjerg.moltke.01@regionh.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Wijayasinghe N, Ringsted TK, Bischoff JM, Kehlet H, Werner MU. The role of peripheral afferents in persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial of ultrasound-guided tender point blockade. Br J Anaesth. 2016 Jun;116(6):829-37. doi: 10.1093/bja/aew071.</citation>
    <PMID>27199314</PMID>
  </reference>
  <reference>
    <citation>Haroutounian S, Nikolajsen L, Bendtsen TF, Finnerup NB, Kristensen AD, Hasselstr√∏m JB, Jensen TS. Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy. Pain. 2014 Jul;155(7):1272-1279. doi: 10.1016/j.pain.2014.03.022. Epub 2014 Apr 2.</citation>
    <PMID>24704366</PMID>
  </reference>
  <reference>
    <citation>Haroutounian S, Ford AL, Frey K, Nikolajsen L, Finnerup NB, Neiner A, Kharasch ED, Karlsson P, Bottros MM. How central is central poststroke pain? The role of afferent input in poststroke neuropathic pain: a prospective, open-label pilot study. Pain. 2018 Jul;159(7):1317-1324. doi: 10.1097/j.pain.0000000000001213.</citation>
    <PMID>29570507</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Finn Borgbjerg Moltke</investigator_full_name>
    <investigator_title>MD, clinical professor</investigator_title>
  </responsible_party>
  <keyword>Peripheral input</keyword>
  <keyword>Trigger point injection</keyword>
  <keyword>Post operative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

